{{indexedTitle}} appears in the content of this record.
{{title}} can only be used in the library.
A copy of {{title}} has been set aside for library use only.
Antitrust concerns and the FDA approval process :
hearing before the Subcommittee on Regulatory Reform, Commercial and Antitrust Law of the Committee on the Judiciary, House of Representatives, One Hundred Fifteenth Congress, first session, July 27, 2017.
Antitrust Concerns And The FDA Approval Process : Hearing Before The Subcommittee On Regulatory Reform, Commercial And Antitrust Law Of The Committee On The Judiciary, House Of Representatives, One Hundred Fifteenth Congress, First Session, July 27, 2017.
United States.
U.S. Government Publishing Office,
2018.
{{indexedTitle}} appears in the content of this record.
{{title}} can only be used in the library.
A copy of {{title}} has been set aside for library use only.
Assessing the impact of a safe and equitable biosimilar policy in the United States :
hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, first session, May 2, 2007.
Assessing The Impact Of A Safe And Equitable Biosimilar Policy In The United States : Hearing Before The Subcommittee On Health Of The Committee On Energy And Commerce, House Of Representatives, One Hundred Tenth Congress, First Session, May 2, 2007.
United States.
U.S. Government Printing Office,
2008.
{{indexedTitle}} appears in the content of this record.
{{title}} can only be used in the library.
A copy of {{title}} has been set aside for library use only.
Closing the gaps in Hatch-Waxman :
assuring greater access to affordable pharmaceuticals : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Seventh Congress, second session, on examining certain provisions of the 1984 Drug Price Competition and Patent Term Restoration Act, known as the Hatch-Waxman Act, assuring greater access to affordable pharmaceuticals, May 8, 2002.
Closing The Gaps In Hatch-Waxman : Assuring Greater Access To Affordable Pharmaceuticals : Hearing Before The Committee On Health, Education, Labor, And Pensions, United States Senate, One Hundred Seventh Congress, Second Session, On Examining Certain Provisions Of The 1984 Drug Price Competition And Patent Term Restoration Act, Known As The Hatch-Waxman Act, Assuring Greater Access To Affordable Pharmaceuticals, May 8, 2002.
United States.
U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O. [Congressional Sales Office],
2002.
{{indexedTitle}} appears in the content of this record.
{{title}} can only be used in the library.
A copy of {{title}} has been set aside for library use only.
Closing the gaps in Hatch-Waxman :
assuring greater access to affordable pharmaceuticals : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Seventh Congress, second session on examining certain provisions of the 1984 Drug Price Competition and Patent Term Restoration Act, known as the Hatch-Waxman Act, assuring greater access to affordable pharmaceuticals, May 8, 2002.
Closing The Gaps In Hatch-Waxman : Assuring Greater Access To Affordable Pharmaceuticals : Hearing Before The Committee On Health, Education, Labor, And Pensions, United States Senate, One Hundred Seventh Congress, Second Session On Examining Certain Provisions Of The 1984 Drug Price Competition And Patent Term Restoration Act, Known As The Hatch-Waxman Act, Assuring Greater Access To Affordable Pharmaceuticals, May 8, 2002.
United States.
U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., [Congressional Sales Office],
2002.
{{indexedTitle}} appears in the content of this record.
{{title}} can only be used in the library.
A copy of {{title}} has been set aside for library use only.
Competition in the drug industry :
hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, Ninety-seventh Congress, first session, March 10, 1981.
Competition In The Drug Industry : Hearing Before The Subcommittee On Oversight And Investigations Of The Committee On Energy And Commerce, House Of Representatives, Ninety-Seventh Congress, First Session, March 10, 1981.
United States.
U.S. G.P.O.,
1981.
{{indexedTitle}} appears in the content of this record.
{{title}} can only be used in the library.
A copy of {{title}} has been set aside for library use only.
Competition in the drug industry :
hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, Ninety-seventh Congress, first session, March 10, 1981.
Competition In The Drug Industry : Hearing Before The Subcommittee On Oversight And Investigations Of The Committee On Energy And Commerce, House Of Representatives, Ninety-Seventh Congress, First Session, March 10, 1981.
United States.
U.S. Government Printing Office,
1981.
{{indexedTitle}} appears in the content of this record.
{{title}} can only be used in the library.
A copy of {{title}} has been set aside for library use only.
Examining the Senate and House versions of the "Greater Access to Affordable Pharmaceuticals Act" :
hearing before the Committee on the Judiciary, United States Senate, One Hundred Eighth Congress, first session, August 1, 2003.
Examining The Senate And House Versions Of The "Greater Access To Affordable Pharmaceuticals Act" : Hearing Before The Committee On The Judiciary, United States Senate, One Hundred Eighth Congress, First Session, August 1, 2003.
United States.
U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O.,
2004.
{{indexedTitle}} appears in the content of this record.
{{title}} can only be used in the library.
A copy of {{title}} has been set aside for library use only.
Examining the Senate and House versions of the "Greater Access to Affordable Pharmaceuticals Act" :
hearing before the Committee on the Judiciary, United States Senate, One Hundred Eighth Congress, first session, August 1, 2003.
Examining The Senate And House Versions Of The "Greater Access To Affordable Pharmaceuticals Act" : Hearing Before The Committee On The Judiciary, United States Senate, One Hundred Eighth Congress, First Session, August 1, 2003.
United States.
U.S. Government Printing Office,
2004.
{{indexedTitle}} appears in the content of this record.
{{title}} can only be used in the library.
A copy of {{title}} has been set aside for library use only.
FDA's generic drug application policy :
hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundredth Congress, second session, July 28, 1988.
FDA's Generic Drug Application Policy : Hearing Before The Subcommittee On Oversight And Investigations Of The Committee On Energy And Commerce, House Of Representatives, One Hundredth Congress, Second Session, July 28, 1988.
United States.
U.S. G.P.O. : For sale by the Supt. of Docs., Congressional Sales Office, U.S. G.P.O.,
[1989]
{{indexedTitle}} appears in the content of this record.
{{title}} can only be used in the library.
A copy of {{title}} has been set aside for library use only.
FDA's generic drug application policy :
hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundredth Congress, second session, July 28, 1988.
FDA's Generic Drug Application Policy : Hearing Before The Subcommittee On Oversight And Investigations Of The Committee On Energy And Commerce, House Of Representatives, One Hundredth Congress, Second Session, July 28, 1988.
United States.
U.S. Government Printing Office,
1989.
{{indexedTitle}} appears in the content of this record.
{{title}} can only be used in the library.
A copy of {{title}} has been set aside for library use only.
FDA's generic drug approval process :
hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred First Congress, first session.
FDA's Generic Drug Approval Process : Hearings Before The Subcommittee On Oversight And Investigations Of The Committee On Energy And Commerce, House Of Representatives, One Hundred First Congress, First Session.
United States.
U.S. G.P.O. : For sale by the Supt. of Docs., Congressional Sales Office, U.S. G.P.O.,
1989-1991.
{{indexedTitle}} appears in the content of this record.
{{title}} can only be used in the library.
A copy of {{title}} has been set aside for library use only.
FDA's generic drug approval process.
hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred First Congress, first session.
FDA's Generic Drug Approval Process. Hearings Before The Subcommittee On Oversight And Investigations Of The Committee On Energy And Commerce, House Of Representatives, One Hundred First Congress, First Session.
United States.
U.S. Government Printing Office,
1989.
{{indexedTitle}} appears in the content of this record.
{{title}} can only be used in the library.
A copy of {{title}} has been set aside for library use only.
FDA's generic drug approval process.
hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred First Congress, first session.
FDA's Generic Drug Approval Process. Hearings Before The Subcommittee On Oversight And Investigations Of The Committee On Energy And Commerce, House Of Representatives, One Hundred First Congress, First Session.
United States.
U.S. Government Printing Office,
1990.
{{indexedTitle}} appears in the content of this record.
{{title}} can only be used in the library.
A copy of {{title}} has been set aside for library use only.
FDA's generic drug approval process.
hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred First Congress, first session.
FDA's Generic Drug Approval Process. Hearings Before The Subcommittee On Oversight And Investigations Of The Committee On Energy And Commerce, House Of Representatives, One Hundred First Congress, First Session.
United States.
U.S. Government Printing Office,
1991.
{{indexedTitle}} appears in the content of this record.
{{title}} can only be used in the library.
A copy of {{title}} has been set aside for library use only.
FDA's generic drug enforcement and approval process :
hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, first session, March 7 and June 5, 1991.
FDA's Generic Drug Enforcement And Approval Process : Hearings Before The Subcommittee On Oversight And Investigations Of The Committee On Energy And Commerce, House Of Representatives, One Hundred Second Congress, First Session, March 7 And June 5, 1991.
United States.
U.S. G.P.O. : For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office,
1992.
{{indexedTitle}} appears in the content of this record.
{{title}} can only be used in the library.
A copy of {{title}} has been set aside for library use only.
FDA's generic drug enforcement and approval process :
hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, first session, March 7 and June 5, 1991.
FDA's Generic Drug Enforcement And Approval Process : Hearings Before The Subcommittee On Oversight And Investigations Of The Committee On Energy And Commerce, House Of Representatives, One Hundred Second Congress, First Session, March 7 And June 5, 1991.
United States.
U.S. Government Printing Office,
1992.
{{indexedTitle}} appears in the content of this record.
{{title}} can only be used in the library.
A copy of {{title}} has been set aside for library use only.
From joint pain to pocket pain :
cost and competition among rheumatoid arthritis therapies : hearing before the Special Committee on Aging, United States Senate, One Hundred Fifteenth Congress, second session, Washington, DC, February 7, 2018.
From Joint Pain To Pocket Pain : Cost And Competition Among Rheumatoid Arthritis Therapies : Hearing Before The Special Committee On Aging, United States Senate, One Hundred Fifteenth Congress, Second Session, Washington, DC, February 7, 2018.
United States.
U.S. Government Publishing Office,
2019.
{{indexedTitle}} appears in the content of this record.
{{title}} can only be used in the library.
A copy of {{title}} has been set aside for library use only.
The generic drug maze :
speeding access to affordable life-saving drugs : hearing before the Special Committee on Aging, United States Senate, One Hundred Ninth Congress, second session, Washington, DC, July 20, 2006.
The Generic Drug Maze : Speeding Access To Affordable Life-Saving Drugs : Hearing Before The Special Committee On Aging, United States Senate, One Hundred Ninth Congress, Second Session, Washington, DC, July 20, 2006.
United States.
U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O.,
2006.
{{indexedTitle}} appears in the content of this record.
{{title}} can only be used in the library.
A copy of {{title}} has been set aside for library use only.
The generic drug maze :
speeding access to affordable life-saving drugs : hearing before the Special Committee on Aging, United States Senate, One Hundred Ninth Congress, second session, Washington, DC, July 20, 2006.
The Generic Drug Maze : Speeding Access To Affordable Life-Saving Drugs : Hearing Before The Special Committee On Aging, United States Senate, One Hundred Ninth Congress, Second Session, Washington, DC, July 20, 2006.
United States.
U.S. Government Printing Office,
2006.
{{indexedTitle}} appears in the content of this record.
{{title}} can only be used in the library.
A copy of {{title}} has been set aside for library use only.
Increasing generic drug use :
savings for seniors and Medicare : hearing before the Special Committee on Aging, United States Senate, One Hundred Ninth Congress, second session, Washington, DC, September 21, 2006.
Increasing Generic Drug Use : Savings For Seniors And Medicare : Hearing Before The Special Committee On Aging, United States Senate, One Hundred Ninth Congress, Second Session, Washington, DC, September 21, 2006.
United States.
U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O.,
2007.
{{indexedTitle}} appears in the content of this record.
{{title}} can only be used in the library.
A copy of {{title}} has been set aside for library use only.
Increasing generic drug use :
savings for seniors and Medicare : hearing before the Special Committee on Aging, United States Senate, One Hundred Ninth Congress, second session, Washington, DC, September 21, 2006.
Increasing Generic Drug Use : Savings For Seniors And Medicare : Hearing Before The Special Committee On Aging, United States Senate, One Hundred Ninth Congress, Second Session, Washington, DC, September 21, 2006.
United States.
U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O.,
2007.
{{indexedTitle}} appears in the content of this record.
{{title}} can only be used in the library.
A copy of {{title}} has been set aside for library use only.
The law of biologic medicine :
hearing before the Committee on the Judiciary, United States Senate, One Hundred Eighth Congress, second session, June 23, 2004.
The Law Of Biologic Medicine : Hearing Before The Committee On The Judiciary, United States Senate, One Hundred Eighth Congress, Second Session, June 23, 2004.
United States.
U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O.,
2004.
{{indexedTitle}} appears in the content of this record.
{{title}} can only be used in the library.
A copy of {{title}} has been set aside for library use only.
The law of biologic medicine :
hearing before the Committee on the Judiciary, United States Senate, One Hundred Eighth Congress, second session, June 23, 2004.
The Law Of Biologic Medicine : Hearing Before The Committee On The Judiciary, United States Senate, One Hundred Eighth Congress, Second Session, June 23, 2004.
United States.
U.S. Government Printing Office,
2004.
{{indexedTitle}} appears in the content of this record.
{{title}} can only be used in the library.
A copy of {{title}} has been set aside for library use only.
Medicare Part D, prescription drug benefit :
increasing use and access of affordable prescription drugs : a report of the Special Committee on Aging, United States Senate.
Medicare Part D, Prescription Drug Benefit : Increasing Use And Access Of Affordable Prescription Drugs : A Report Of The Special Committee On Aging, United States Senate.
United States.
U.S. Government Publishing Office,
2014.
{{indexedTitle}} appears in the content of this record.
{{title}} can only be used in the library.
A copy of {{title}} has been set aside for library use only.
Pay-for-delay deals :
limiting competition and costing consumers : hearing before the Subcommittee on Antitrust, Competition Policy and Consumer Rights of the Committee on the Judiciary, United States Senate, One Hundred Thirteenth Congress, first session, July 23, 2013.
Pay-For-Delay Deals : Limiting Competition And Costing Consumers : Hearing Before The Subcommittee On Antitrust, Competition Policy And Consumer Rights Of The Committee On The Judiciary, United States Senate, One Hundred Thirteenth Congress, First Session, July 23, 2013.
United States.
U.S. Government Printing Office,
2013.
{{indexedTitle}} appears in the content of this record.
{{title}} can only be used in the library.
A copy of {{title}} has been set aside for library use only.
Pay-for-delay deals :
limiting competition and costing consumers : hearing before the Subcommittee on Antitrust, Competition Policy and Consumer Rights of the Committee on the Judiciary, United States Senate, One Hundred Thirteenth Congress, first session, July 23, 2013.
Pay-For-Delay Deals : Limiting Competition And Costing Consumers : Hearing Before The Subcommittee On Antitrust, Competition Policy And Consumer Rights Of The Committee On The Judiciary, United States Senate, One Hundred Thirteenth Congress, First Session, July 23, 2013.
United States.
U.S. Government Printing Office,
2013.
{{indexedTitle}} appears in the content of this record.
{{title}} can only be used in the library.
A copy of {{title}} has been set aside for library use only.
Recent developments which may impact consumer access to, and demand for, pharmaceuticals :
hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, first session, June 13, 2001.
Recent Developments Which May Impact Consumer Access To, And Demand For, Pharmaceuticals : Hearing Before The Subcommittee On Health Of The Committee On Energy And Commerce, House Of Representatives, One Hundred Seventh Congress, First Session, June 13, 2001.
United States.
U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., [Congressional Sales Office],
2001.
{{indexedTitle}} appears in the content of this record.
{{title}} can only be used in the library.
A copy of {{title}} has been set aside for library use only.
Role of commissioner of food and drugs :
hearing before the Committee on Labor and Human Resources, United States Senate, One Hundred Second Congress, first session, on examining the role of the current commissioner of the Food and Drug Administration, March 6, 1991.
Role Of Commissioner Of Food And Drugs : Hearing Before The Committee On Labor And Human Resources, United States Senate, One Hundred Second Congress, First Session, On Examining The Role Of The Current Commissioner Of The Food And Drug Administration, March 6, 1991.
United States.
U.S. G.P.O. : For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office,
1992.
{{indexedTitle}} appears in the content of this record.
{{title}} can only be used in the library.
A copy of {{title}} has been set aside for library use only.
Role of Commissioner of Food and Drugs :
hearing before the Committee on Labor and Human Resources, United States Senate, One Hundred Second Congress, first session on examining the role of the current Commissioner of the Food and Drug Administration, March 6, 1991.
Role Of Commissioner Of Food And Drugs : Hearing Before The Committee On Labor And Human Resources, United States Senate, One Hundred Second Congress, First Session On Examining The Role Of The Current Commissioner Of The Food And Drug Administration, March 6, 1991.
United States.
U.S. Government Printing Office,
1992.
{{indexedTitle}} appears in the content of this record.
{{title}} can only be used in the library.
A copy of {{title}} has been set aside for library use only.
Rx for generic drug safety :
accurate information for older Americans : hearing before the Subcommittee on Housing and Consumer Interests of the Select Committee on Aging, House of Representatives, One Hundred First Congress, second session, March 1, 1990.
Rx For Generic Drug Safety : Accurate Information For Older Americans : Hearing Before The Subcommittee On Housing And Consumer Interests Of The Select Committee On Aging, House Of Representatives, One Hundred First Congress, Second Session, March 1, 1990.
United States.
U.S. G.P.O. : For sale by the Supt. of Docs., Congressional Sales Office, U.S. G.P.O.,
1990.
{{indexedTitle}} appears in the content of this record.
{{title}} can only be used in the library.
A copy of {{title}} has been set aside for library use only.
Rx for generic drug safety :
accurate information for older Americans : hearing before the Subcommittee on Housing and Consumer Interests of the Select Committee on Aging, House of Representatives, One Hundred First Congress, second session, March 1, 1990.
Rx For Generic Drug Safety : Accurate Information For Older Americans : Hearing Before The Subcommittee On Housing And Consumer Interests Of The Select Committee On Aging, House Of Representatives, One Hundred First Congress, Second Session, March 1, 1990.
United States.
U.S. Government Printing Office,
1990.
{{indexedTitle}} appears in the content of this record.
{{title}} can only be used in the library.
A copy of {{title}} has been set aside for library use only.
Safe and affordable biotech drugs :
the need for a generic pathway : hearing before the Committee on Oversight and Government Reform, House of Representatives, One Hundred Tenth Congress, first session, March 26, 2007.
Safe And Affordable Biotech Drugs : The Need For A Generic Pathway : Hearing Before The Committee On Oversight And Government Reform, House Of Representatives, One Hundred Tenth Congress, First Session, March 26, 2007.
United States.
U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O.,
2008.
{{indexedTitle}} appears in the content of this record.
{{title}} can only be used in the library.
A copy of {{title}} has been set aside for library use only.
Safe and affordable biotech drugs :
the need for a generic pathway : hearing before the Committee on Oversight and Government Reform, House of Representatives, One Hundred Tenth Congress, first session, March 26, 2007.
Safe And Affordable Biotech Drugs : The Need For A Generic Pathway : Hearing Before The Committee On Oversight And Government Reform, House Of Representatives, One Hundred Tenth Congress, First Session, March 26, 2007.
United States.
U.S. Government Printing Office,
2008.
